A new mineral sunscreen formulation developed by researchers at UCLA promises to address a long-standing complaint among dermatologists and consumers alike: the noticeable white cast often left on skin after application. The breakthrough, announced February 3, 2026, centers around a change in the shape of zinc oxide particles, potentially making daily sunscreen use more appealing, particularly for people with darker skin tones. This innovation could significantly impact public health by encouraging wider adoption of sun protection, a critical preventative measure against skin cancer.
For decades, dermatologists have emphasized the importance of daily sunscreen application to shield against harmful ultraviolet (UV) radiation. Excessive exposure to UV radiation is recognized as the leading preventable cause of skin cancer, the most common cancer in the United States. Despite this, many individuals still forgo sunscreen, and a key reason is the aesthetic issue of the white or grayish tint left behind by many mineral-based formulas.
Addressing the White Cast Problem
The UCLA team, led by AJ Addae, a doctoral candidate in chemical biology, and Paul S. Weiss, a distinguished professor of chemistry & biochemistry, bioengineering, and materials science & engineering, focused on the physical properties of zinc oxide, a common active ingredient in mineral sunscreens. Instead of seeking a new chemical ingredient, the researchers discovered that altering the shape of the zinc oxide particles could dramatically reduce the unwanted white cast. Laboratory tests and controlled skin applications showed that the modified particles appeared warmer and more closely matched natural skin tones.
The challenge with traditional zinc oxide lies in its tendency to scatter visible light, creating the opaque, chalky appearance. The UCLA researchers’ approach tackles this issue at the particle level, aiming for a more transparent application without compromising UV protection. While the specific details of the particle shape modification haven’t been widely publicized, the initial findings suggest a significant improvement in cosmetic acceptability.
How the New Formulation Works
The research, conducted at the UCLA Health Jonsson Comprehensive Cancer Center, doesn’t involve altering the chemical composition of the zinc oxide itself. Instead, it’s a physical modification – a change in the particle’s geometry. This is a crucial distinction, as it potentially streamlines the regulatory approval process, avoiding the lengthy and costly evaluations required for new chemical entities. The team’s operate suggests that a simple change in manufacturing processes could yield a more user-friendly sunscreen.
The researchers haven’t yet disclosed whether the new formulation requires any changes to the concentration of zinc oxide used in sunscreen. Maintaining effective UV protection is paramount, and any alteration to the particle shape must not compromise the sunscreen’s ability to block harmful rays. Further testing will be needed to confirm long-term efficacy and safety.
Impact on Sunscreen Adoption and Skin Health
The potential impact of this development extends beyond cosmetic improvements. The white cast has been a significant barrier to sunscreen use, particularly among individuals with darker skin tones, who often find the contrast particularly noticeable. By reducing this visual effect, the UCLA formulation could encourage more consistent sunscreen application across a broader range of skin types.
Increased sunscreen use translates directly to reduced rates of skin cancer. According to the American Cancer Society, melanoma, the deadliest form of skin cancer, will account for an estimated 100,640 new cases in 2024. While mineral sunscreens are often preferred by dermatologists due to their generally gentler formulation and environmental considerations, their aesthetic drawbacks have limited their widespread adoption. This new formulation could bridge that gap.
Next Steps and Commercialization
The UCLA researchers are currently focused on further refining the formulation and conducting more extensive testing to validate its efficacy and safety. The next phase will likely involve larger-scale clinical trials to assess performance across diverse skin types and environmental conditions. The team is similarly exploring potential partnerships with sunscreen manufacturers to bring the technology to market.
While a specific timeline for commercial availability hasn’t been announced, the researchers express optimism that the new formulation could be available to consumers within the next few years. The relatively straightforward nature of the particle modification suggests a faster path to market compared to developing entirely new sunscreen ingredients.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
The development of a mineral sunscreen that effectively minimizes the white cast represents a significant step forward in promoting sun safety and protecting public health. As the research progresses and the formulation moves closer to commercialization, it holds the promise of making daily sunscreen use more accessible and appealing to everyone. We will continue to follow this story and provide updates as they become available.
What are your thoughts on this new sunscreen formulation? Share your comments below, and please share this article with anyone who might find it helpful.
